MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
This Quarter Return
+13.23%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$17.2M
AUM Growth
+$17.2M
(+8.2%)
Cap. Flow
-$104K
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
72.09%
Holding
23
New
8
Increased
3
Reduced
9
Closed
3
Top Buys
| 1 |
Cigna
CI
|
$784K |
| 2 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$535K |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$428K |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$424K |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$410K |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$974K |
| 2 |
Labcorp
LH
|
$723K |
| 3 |
Incyte
INCY
|
$710K |
| 4 |
CYNO
Cynosure, Inc. Class A
CYNO
|
$704K |
| 5 |
Humana
HUM
|
$486K |
Sector Composition
| 1 | Healthcare | 85.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Universal Health Services
UHS
$11.6B
| $2.08M | 12.11% | 14,663 -790 | -5% | -$112K |
|
2
United Therapeutics
UTHR
$13.8B
| $1.74M | 10.12% | 10,009 -799 | -7% | -$139K |
|
3
Eli Lilly
LLY
$657B
| $1.31M | 7.64% | 15,738 +1,546 | +11% | +$129K |
|
4
DexCom
DXCM
$29.5B
| $1.24M | 7.21% | 15,504 -828 | -5% | -$66.2K |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.17M | 6.8% | 2,294 -98 | -4% | -$50K |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.08M | 6.25% | 5,949 +2,269 | +62% | +$410K |
|
|
THOR
7
DELISTED
THORATEC CORPORATION
THOR
| $1.05M | 6.09% | 23,486 -1,279 | -5% | -$57K |
|
|
CYNO
8
DELISTED
Cynosure, Inc. Class A
CYNO
| $983K | 5.71% | 25,475 -18,254 | -42% | -$704K |
|
|
MNK
9
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $963K | 5.6% | 8,177 -363 | -4% | -$42.8K |
|
|
10
Cigna
CI
$80.3B
| $784K | 4.56% | +4,842 | New | +$784K |
|
|
11
Humana
HUM
$36.5B
| $739K | 4.3% | 3,862 -2,541 | -40% | -$486K |
|
12
Zoetis
ZTS
$69.3B
| $721K | 4.19% | 14,956 +209 | +1% | +$10.1K |
|
13
Cencora
COR
$56.5B
| $713K | 4.14% | 6,707 -10 | -0.1% | -$1.06K |
|
|
ZLTQ
14
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $535K | 3.11% | +18,165 | New | +$535K |
|
|
RCPT
15
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $428K | 2.49% | +2,251 | New | +$428K |
|
|
SGEN
16
DELISTED
Seagen Inc. Common Stock
SGEN
| $424K | 2.46% | +8,768 | New | +$424K |
|
17
Neurocrine Biosciences
NBIX
$13.8B
| $410K | 2.38% | +8,593 | New | +$410K |
|
18
Ultragenyx Pharmaceutical
RARE
$2.89B
| $338K | 1.96% | +3,299 | New | +$338K |
|
19
Catalyst Pharmaceutical
CPRX
$2.52B
| $334K | 1.94% | +80,890 | New | +$334K |
|
|
AGEN
20
Agenus
AGEN
$133M
| $160K | 0.93% | +18,517 | New | +$160K |
|
|
21
Incyte
INCY
$16.5B
| – | – | -7,742 | Closed | -$710K |
|
|
22
Labcorp
LH
$23.1B
| – | – | -5,735 | Closed | -$723K |
|
|
MDCO
23
DELISTED
Medicines Co
MDCO
| – | – | -34,744 | Closed | -$974K |
|